| 摘要 |
The invention relates to novel substituted oxazolidines of formula (I) where in R1 and R2 are simultaneously hydrogen or both together are the identical low er alkyl radical, and to the salts thereof in racemic and chiral form, to a process for the preparation of said compounds, to pharmaceutical composition s containing them, and to the use thereof as medicaments. The compounds have a stimulating effect on beta-adrenergic receptors and can be used, inter alia, for the treatment of diseases associated with reversible obstruction of the respiratory tract, typically asthma and chronic bronchitis, and also for inflammations of different origin.
|
